Full text is available at the source.
The REV‐ERB antagonist SR8278 modulates keratinocyte viability in response to UVA and UVB radiation
REV-ERB blocker SR8278 changes skin cell survival after UVA and UVB exposure
AI simplified
Abstract
SR8278 may promote keratinocyte viability in UVB-irradiated cells but has limited utility for UV photoprotection.
- SR8278 did not significantly affect the nucleotide excision repair process or the expression of the clock-regulated NER factor XPA.
- Both KS15 and SR8278 absorb UV light, which may limit initial UV photoproduct formation in DNA.
- SR8278 increased cell viability in UVB-irradiated keratinocytes, even when the core circadian clock protein BMAL1 was disrupted.
- SR8278 sensitized keratinocytes to UVA light, potentially due to toxic reactive oxygen species production.
- Results suggest SR8278 could lead to phototoxicity in humans or mammals exposed to solar radiation.
AI simplified